SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-19-000691
Filing Date
2019-10-31
Accepted
2019-10-31 17:26:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR ACLARIS THERAPEUTICS, INC. BY MFN PARTNERS, LP s13g_103019-aclaris.htm SC 13G 129879
  Complete submission text file 0000904454-19-000691.txt   131327
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 191184588
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116 617-443-2040
MFN Partners Management, LP (Filed by) CIK: 0001732811 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G